Twist Bioscience Corporation (TWST)
NASDAQ
Closed
Aug 25, 2026
Day's Range
141.4152 wk Range
23.30Overview - TWST - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
8.77B
P/E (Trailing)
‪-116.47‬
P/E (Forward)
‪-222.31‬
PEG Ratio
‪0.44‬
Price / Sales (TTM)
‪20.44‬
Price / Book
‪19.79‬
EV / EBITDA
‪-76.08‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪-31.66%‬
Operating Margin
‪-30.64%‬
Return on Assets
‪-13.08%‬
Return on Equity
‪-29.59%‬
Ownership
Shares Outstanding
62.67M
Float
61.26M
Short % of Shares Outstanding
‪28.74%‬
Held by Insiders
‪0.99%‬
Held by Institutions
‪115.98%‬
Price stats
Beta
‪2.15‬
50-Day Avg
‪101.30‬
200-Day Avg
‪59.85‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - TWST - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - TWST - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products through a proprietary semiconductor-based platform. This disruptive technology synthesizes DNA on silicon chips rather than traditional plastic plates, enabling high-quality, high-throughput production…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
